Activity

Filter

Cancel
Date Panel Item Activity
7 actions
Chromosome Breakage Disorders v1.9 AARS Zornitza Stark Phenotypes for gene: AARS were changed from Trichothiodystrophy, MONDO:0018053 to Trichothiodystrophy, MONDO:0018053; Trichothiodystrophy 8, nonphotosensitive 619691
Chromosome Breakage Disorders v1.8 AARS Zornitza Stark edited their review of gene: AARS: Changed phenotypes: Trichothiodystrophy, MONDO:0018053, Trichothiodystrophy 8, nonphotosensitive, MIM# 619691
Chromosome Breakage Disorders v1.7 AARS Zornitza Stark Marked gene: AARS as ready
Chromosome Breakage Disorders v1.7 AARS Zornitza Stark Gene: aars has been classified as Amber List (Moderate Evidence).
Chromosome Breakage Disorders v1.7 AARS Zornitza Stark Classified gene: AARS as Amber List (moderate evidence)
Chromosome Breakage Disorders v1.7 AARS Zornitza Stark Gene: aars has been classified as Amber List (Moderate Evidence).
Chromosome Breakage Disorders v1.6 AARS Zornitza Stark gene: AARS was added
gene: AARS was added to Chromosome Breakage Disorders. Sources: Literature
Mode of inheritance for gene: AARS was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: AARS were set to 33909043
Phenotypes for gene: AARS were set to Trichothiodystrophy, MONDO:0018053
Review for gene: AARS was set to AMBER
Added comment: PMID: 33909043 - Botta et al 2021 - using WES or WGS analysis of 34 unsolved cases with multi-system phenotypes, but with hair alterations that are typical of trichothiodystrophy but no reported photosensitivity, they identified 2 unrelated cases carrying 4 potentially pathogenic variants in the AARS1 gene (previously known as AARSB). Both patients had very rare compound heterozygous missense variants. In one family there was an older affected sibling but segregation data was not available for either family. Functional studies suggest that the variants affects gene product stability.

Amber rating as 2 families only, and uncertain of underlying mechanism (unlikely chromosome breakage, gene is associated with other disease entities) but included due to phenotypic overlap.
Sources: Literature